Noninvasive Detection of Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Teratoma with an Integrin-Targeting Agent 99mTc-3PRGD2
Noninvasive Detection of Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Teratoma with an Integrin-Targeting Agent 99mTc-3PRGD2
复制标题
使用整合素靶向剂 99mTc-3PRGD2 无创检测人诱导多能干细胞 (hiPSC) 衍生的畸胎瘤
DOI:
10.1007/s11307-012-0571-1
复制
发表时间:
2013-02
期刊:
影响因子:
--
通讯作者:
李扬
中科院分区:
文献类型:
--
作者:
李扬
PurposeSince their discovery in 2006, induced pluripotent stem cells (iPSCs) have gained increasing interest for tissue regeneration and transplantation therapies. However, teratoma formation after iPSC transplantation is one of the most serious drawbacks that may limit their further clinical application. We investigated here whether human iPSC-derived teratomas could be detected by an integrin-targeting agent 99mTc-PEG4-E[PEG4-c(RGDfK)]2 (99mTc-3PRGD2).MethodsHuman-induced pluripotent stem cells (hiPSCs) were generated and characterized. In vitro integrin αvβ3 expression levels of hiPSC- and hiPSC-derived teratoma cells were determined by flow cytometry. 99mTc-3PRGD2 was prepared, and planar gamma imaging and biodistribution studies were carried out in teratoma-bearing severe combined immunodeficient (SCID) mice. Positron emission tomography (PET) imaging of teratomas with 2-deoxy-2-[18F]fluoro-d-glucose (18F-FDG) was also performed for comparison. Integrin αvβ3 expression in teratoma tissues was determined by immunofluorescence staining.Results99mTc-3PRGD2 showed high (2.82 ± 0.21 and 2.69 ± 0.73%ID/g at 0.5 and 1 h pi, respectively) and specific (teratoma uptake decreased from 2.69 ± 0.73 to 0.53 ± 0.26%ID/g after blocking with cold 3PRGD2) uptake in teratoma tissues, and planar gamma imaging demonstrated the feasibility of noninvasively detecting the teratoma formation with 99mTc-3PRGD2. 18F-FDG showed low teratoma uptake and thus failed to detect the teratomas. Ex vivo immunofluorescence staining validated the integrin αvβ3 expression in the vasculature during teratoma formation.ConclusionGamma imaging with 99mTc-3PRGD2 is a promising approach for the noninvasive monitoring of tumorigenicity after hiPSCs transplantation.
登录
查看更多内容
影响因子:
11.2
作者:
Cao F;Li Z;Lee A;Liu Z;Chen K;Wang H;Cai W;Chen X;Wu JC
通讯作者:
Wu JC
影响因子:
2.1
作者:
L. J. Putra;N. Lawrentschuk;N. Lawrentschuk;Z. Ballok;A. Hannah;A. Poon;A. Tauro;I. Davis;I. Davis;R. Hicks;D. Bolton;A. Scott;A. Scott
通讯作者:
L. J. Putra;N. Lawrentschuk;N. Lawrentschuk;Z. Ballok;A. Hannah;A. Poon;A. Tauro;I. Davis;I. Davis;R. Hicks;D. Bolton;A. Scott;A. Scott
影响因子:
4.7
作者:
Liu S
通讯作者:
Liu S
影响因子:
37.8
作者:
Cao, F;Lin, S;Wu, JC
通讯作者:
Wu, JC
DOI:
10.1016/s0093-3619(08)70915-8
发表时间:
2008
期刊:
Yearbook of Dermatology and Dermatologic Surgery
影响因子:
--
作者:
B. Thiers
通讯作者:
B. Thiers